However, surface expression of GRP78 has been observed in varying tumor cell lines and with ER stressors known to upregulate surface GRP78 expression [39] allowing for potential future studies aimed at investigating the effects of exogenous GRP78 blocking antibodies on N-cad activity. This evidence concerns the gene CDH2 and neoplasm.